Stockscreener 앱 받기
0.00
100.00%
-10.44
전일 마감가:
$10.44
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$N/A
수익:
-
순이익/손실:
$3.04M
주가수익비율:
0.00
EPS:
0.1382
순현금흐름:
-
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
+0.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$10.90
Translational Development Acquisition Corp Stock (TDACU) Company Profile
명칭
Translational Development Acquisition Corp
전화
(413) 204-2769
주소
52 E 83RD ST., NEW YORK
TDACU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TDACU
Translational Development Acquisition Corp
|
0.00 | 0 | 0 | 3.04M | 0 | 0.1382 |
|
LION
Lionsgate Studios Corp
|
7.04 | 2.06B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
CCCX
Churchill Capital Corp X
|
14.51 | 795.32M | 0 | 0 | 0 | 0.00 |
|
DMII
Drugs Made In America Acquisition Ii Corp
|
9.88 | 647.88M | 0 | 0 | 0 | 0.00 |
|
BCSS
Bain Capital Gss Investment Corp
|
10.07 | 588.09M | 0 | 0 | 0 | 0.00 |
|
CEPF
Cantor Equity Partners Iv Inc
|
10.29 | 588.65M | 0 | 0 | 0 | 0.00 |
Translational Development Acquisition Corp 주식(TDACU)의 최신 뉴스
Will Translational Development Acquisition Corp. Equity Warrant stock benefit from AI adoption2025 Market Trends & Real-Time Buy Zone Alerts - Newser
Why Translational Development Acquisition Corp. stock could outperform in 2025Gap Down & Stepwise Trade Signal Implementation - Newser
Can Translational Development Acquisition Corp. stock deliver consistent earnings growth2025 Retail Activity & Risk Managed Investment Signals - Newser
Why Translational Development Acquisition Corp. Equity Warrant stock remains resilientQuarterly Investment Review & Weekly Watchlist of Top Performers - Newser
Translational Development Acquisition Corp Equity Warrant Stock Analysis and ForecastIndustrial Stocks Review & Free Rapid Portfolio Appreciation - earlytimes.in
Translational Development (TDACU) Stock Analysis Report | Financials & Insights - Benzinga
Hindustan Foods Limited May Be Forming Higher Low Chartwatchers AlertMarket Insider Reports & Low Risk Trading Ideas - earlytimes.in
Why Translational Development Acquisition Corp. stock appeals to analystsTrade Risk Assessment & AI Based Trade Execution Alerts - newser.com
What Technical Resistance Could Cap Toss the Coin Limiteds Upside - earlytimes.in
Is this a good reentry point in Translational Development Acquisition Corp. Equity Warrant2025 Momentum Check & AI Enhanced Execution Alerts - newser.com
How sustainable is Translational Development Acquisition Corp. Equity Warrant stock dividend payoutTrade Risk Assessment & Smart Allocation Stock Tips - newser.com
How Translational Development Acquisition Corp. stock benefits from tech adoptionRecession Risk & Accurate Buy Signal Notifications - newser.com
Is Translational Development Acquisition Corp. stock overvalued by current metricsJuly 2025 Trends & Stepwise Trade Signal Guides - newser.com
Why Translational Development Acquisition Corp. stock could benefit from AI revolution2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com
Can Translational Development Acquisition Corp. stock double in next 5 yearsMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Can Translational Development Acquisition Corp. stock attract ESG capital inflowsSell Signal & AI Powered Market Entry Strategies - newser.com
Is Translational Development Acquisition Corp. Equity Warrant stock supported by innovation pipelineFed Meeting & Smart Money Movement Alerts - newser.com
Why VNET Group Inc. Depositary Receipt stock remains on buy lists - newser.com
Real time alert setup for Translational Development Acquisition Corp. Equity Warrant performanceGap Down & AI Powered Trade Plan Recommendations - newser.com
Will Translational Development Acquisition Corp. Equity Warrant stock continue dividend increasesQuarterly Risk Review & Expert Verified Movement Alerts - newser.com
Is Translational Development Acquisition Corp. Equity Warrant stock cheap at current valuationRate Cut & Daily Risk Controlled Trade Plans - newser.com
Volatility clustering patterns for Translational Development Acquisition Corp.Quarterly Profit Summary & High Conviction Buy Zone Picks - newser.com
Will Translational Development Acquisition Corp. Equity Warrant stock deliver strong dividend growthLayoff News & Safe Entry Point Alerts - newser.com
Translational Development Acquisition Corp (TDACU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
1.32%
자본화:
|
볼륨(24시간):